When you peruse the figures announced by the ROC's Central Epidemic Command Center, you see that to January 18, 2010, 1051 apparent adverse reactions had been reported. Of these, 892 were associated with the Adimmune vaccine, giving a rate of occurrence of 17.5 cases per 100,000 doses, as against 89 cases or 18.1 per 100,000 for Novartis.
攤開中央疫情指揮中心公布的數據，至 1 月 18 日止，全台 1,051 件疑似不良事件中，國光疫苗有 892 件，發生率為每 10 萬劑 17.5 例；諾華有 89 件，發生率為每 10 萬劑 18.1 例。